Cormorant Asset Management, LP 13D and 13G filings for BioAge Labs, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 3:01 pm Sale | 2025-06-30 | 13G | BioAge Labs, Inc. BIOA | Cormorant Asset Management, LP | 2,140,605 5.970% | -488,924 (-18.59%) | Filing |
| 2025-02-14 3:00 pm Purchase | 2024-12-31 | 13G | BioAge Labs, Inc. BIOA | Cormorant Asset Management, LP | 2,629,529 7.340% | 2,629,529 (New Position) | Filing |